Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Controlled evaluation of combined radiation and bleomycin therapy for squamous cell carcinoma of the esophagus

Journal Article · · Int. J. Radiat. Oncol., Biol. Phys.; (United States)
In a controlled, randomized Eastern Cooperative Oncology Group (ECOG) study 77 evaluable patients with squamous cell carcinoma of the esophagus were treated with radiation therapy alone at a recommended dosage of 5000 to 6000 rad administered over five to six weeks in five or six fractions a week or with radiation given in combination with Bleomycin. Whereas the Bleomycin group experienced the additional toxicity of chemotherapy, Bleomycin did not contribute to therapeutic results in terms of either symptomatic pallation or survival. Further application of this approach by the methods we employed is not indicated. Overall treatment results were discouraging; the five year survival in this group of patients with regionally localized squamous cell carcinoma of the esophagus will not exceed 8%. In a non-randomized comparison, patients treated with 6000 rad did not show a therapeutic advantage over those treated with 5000 rad. Most favorable survival after treatment was seen in patients with lesions in the cervical esophagus and middle one-third of the thoracic esophagus. Least favorable survival was seen with lesions of the upper and lower one-third of the thoracic esophagus.
OSTI ID:
6854533
Journal Information:
Int. J. Radiat. Oncol., Biol. Phys.; (United States), Journal Name: Int. J. Radiat. Oncol., Biol. Phys.; (United States) Vol. 6:7; ISSN IOBPD
Country of Publication:
United States
Language:
English

Similar Records

Patterns of tumor recurrence after definitive irradiation for inoperable non-oat cell carcinoma of the lung. [/sup 60/Co on photons]
Journal Article · Fri Aug 01 00:00:00 EDT 1980 · Int. J. Radiat. Oncol., Biol. Phys.; (United States) · OSTI ID:5007319

Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung - report by the Radiation Therapy Oncology group
Journal Article · Wed Sep 15 00:00:00 EDT 1982 · Cancer (Philadelphia); (United States) · OSTI ID:6566498

Misonidazole and unconventional radiation in advanced squamous cell carcinoma of the esophagus: a phase II study of the Radiation Therapy Oncology Group
Journal Article · Sun Feb 28 23:00:00 EST 1982 · Int. J. Radiat. Oncol., Biol. Phys.; (United States) · OSTI ID:6707506